Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
How has digital health contributed to the fight against COVID-19? What kinds of outcomes has it produced? What have been some unintended consequences of its deployment?
Fresh off an investment infusion of $25 million, a tech startup has launched an ambitious virtual consortium to seek “breakthrough medical discoveries and actionable findings” for the global battle against COVID-19.
The University of Pennsylvania is teaming with Intel to lead a federation of more than two dozen medical and research centers on an AI system for identifying brain tumors.
Researchers in the U.K. and U.S. have developed an automatic prediction model that can tell if someone is infected with COVID-19 based on symptoms alone.
A convolutional neural network trained and internally validated on more than 15,000 lung CT scans has correctly reclassified indeterminate pulmonary nodules into low-risk or high-risk categories.
